PhD, MBBS, MSc
University Research Lecturer
- Senior Research Fellow
Understanding immune recognition and developing cancer immunotherapy.
Development of a T-cell Receptor Mimic Antibody against Wild-Type p53 for Cancer Immunotherapy.
Li D. et al, (2017), Cancer Res, 77, 2699 - 2711
Engineering chimeric human and mouse major histocompatibility complex (MHC) class I tetramers for the production of T-cell receptor (TCR) mimic antibodies.
Li D. et al, (2017), PLoS One, 12
Therapeutic Antibodies against Intracellular Tumor Antigens.
Trenevska I. et al, (2017), Front Immunol, 8
The European antibody network's practical guide to finding and validating suitable antibodies for research.
Roncador G. et al, (2016), MAbs, 8, 27 - 36
The D0 Ig-like domain plays a central role in the stronger binding of KIR3DL2 to B27 free H chain dimers.
Hatano H. et al, (2015), J Immunol, 194, 1591 - 1601